Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-05 Sale |
2021-01-06 7:12 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
2,056 | $122.56 | $251,988 | 16,163 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 7:09 pm |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
10,000 | $125.38 | $1,253,759 | 3,987 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 7:03 pm |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
4,779 | $123.24 | $588,974 | 5,813 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-06 6:58 pm |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
4,258 | $121.13 | $515,774 | 81,788 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-15 6:24 pm |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
42,528 | $130.14 | $5,534,594 | 42,641 (Direct) |
View |
| 2020-12-09 Sale |
2020-12-11 6:08 pm |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
7,472 | $125.02 | $934,176 | 173,074 (Direct) |
View |
| 2020-10-12 Sale |
2020-10-13 7:14 pm |
ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director |
37,500 | $119.36 | $4,475,981 | 5,127 (Direct) |
View |
| 2020-09-11 Sale |
2020-09-15 4:51 pm |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
23,272 | $90.39 | $2,103,466 | 4,422 (Direct) |
View |
| 2020-09-08 Sale |
2020-09-09 5:49 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
2,000 | $89.5 | $179,004 | 19,161 (Direct) |
View |
| 2020-07-09 Sale |
2020-07-13 6:27 pm |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
2,241 | $102.28 | $229,209 | 7,008,510 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-06 6:57 pm |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
50,000 | $96.41 | $4,820,445 | 439,324 (Direct) |
View |
| 2020-07-01 Purchase |
2020-07-06 5:24 pm |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
108,108 | $92.5 | $9,999,990 | 6,971,772 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-29 Option Award |
2021-02-02 6:31 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Hamill Laura Director |
1,415 | $0 | 1,415 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:26 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Nader Francois Director |
4,844 | $0 | 9,971 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 7:12 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
942 | $124.31 | 16,163 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 7:09 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
1,357 | $124.31 | 3,987 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 7:05 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development |
1,735 | $124.31 | 15,372 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 7:03 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
624 | $124.31 | 5,813 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 6:58 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
3,278 | $124.31 | 81,788 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 6:24 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
7,252 | $41.2 | 42,641 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 6:24 pm |
N/A 2025-01-08 |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
42,528 | $0 | 42,641 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 6:24 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
24,986 | $30.17 | 42,641 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 6:24 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
2,590 | $40.61 | 42,641 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 6:24 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
7,700 | $27.97 | 42,641 (Direct) |
View |
| 2020-12-09 Exercise |
2020-12-11 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
3,748 | $41.2 | 173,074 (Direct) |
View |
| 2020-12-09 Exercise |
2020-12-11 6:08 pm |
N/A 2025-01-08 |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
7,472 | $0 | 173,074 (Direct) |
View |
| 2020-12-09 Exercise |
2020-12-11 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
1,151 | $30.17 | 173,074 (Direct) |
View |
| 2020-12-09 Exercise |
2020-12-11 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
1,973 | $40.61 | 173,074 (Direct) |
View |
| 2020-12-09 Exercise |
2020-12-11 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
600 | $27.97 | 173,074 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-13 7:14 pm |
N/A 2024-07-14 |
ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director |
37,500 | $0 | 5,127 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-13 7:14 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director |
20,000 | $28.37 | 5,127 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-13 7:14 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director |
7,500 | $30.17 | 5,127 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-13 7:14 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director |
10,000 | $27.97 | 5,127 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 09:23 am |
N/A 2030-09-15 |
ACCELERON PHARMA INC | XLRN | Hamill Laura Director |
9,339 | $0 | 9,339 (Direct) |
View |
| 2020-09-11 Exercise |
2020-09-15 4:51 pm |
N/A 2026-07-25 |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
23,272 | $0 | 4,422 (Direct) |
View |
| 2020-09-11 Exercise |
2020-09-15 4:51 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
3,272 | $30.17 | 4,422 (Direct) |
View |
| 2020-09-11 Exercise |
2020-09-15 4:51 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
20,000 | $32.98 | 4,422 (Direct) |
View |
| 2020-07-09 Exercise |
2020-07-13 6:27 pm |
N/A 2020-07-09 |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
38,979 | $0 | 7,008,510 (Direct) |
View |
| 2020-07-09 Exercise |
2020-07-13 6:27 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
38,979 | $5.88 | 7,008,510 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 6:57 pm |
N/A 2026-12-01 |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
50,000 | $0 | 439,324 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 6:57 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
50,000 | $35.04 | 439,324 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-05 8:32 pm |
N/A 2030-06-04 |
ACCELERON PHARMA INC | XLRN | Hite Christopher Director |
10,267 | $0 | 10,267 (Direct) |
View |